$143.830
+3.179 (+2.21%)At close
MANE Comparative Benchmarking
In the context of the broader market, MANE competes directly with industry leaders such as BLTE and KNSA. With a market capitalization of $5.80B, it holds a significant position in the sector. When comparing efficiency, MANE's gross margin of N/A stands against BLTE's N/A and KNSA's 90.32%. Such benchmarking helps identify whether Veradermics, Incorporated is trading at a premium or discount relative to its financial performance.
Veradermics Inc Financial Performance
The company has shown a significant increase in total equity, from -122,863,000 USD in Q4 2025 to 813,613,000 USD in Q2 2026, indicating a strong recovery in financial health despite ongoing net losses.
Financials
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.